JAMA Medical News

JAMA Associate Editor John M. Inadomi, MD, discusses clinical highlights from United European Gastroenterology (UEG) Week with UEG president Helena Cortez-Pinto, MD, PhD. Related Content: Highlights From Gastroenterology Week: New Crohn Disease Drug, Redefining Liver Disease, and More

Suchi Saria, an associate professor in computer science at Johns Hopkins, discusses how AI can streamline care, the challenges in healthcare AI integration, the importance of collaborative interdisciplinary teams, exploring the impact of predictive AI in healthcare beyond chatbot technology, and the necessity of guardrails and federal oversight in AI governance.

Discussing the FDA approval of Alzheimer's drug Lecanumab, its effectiveness, high cost, and Medicare coverage; Exploring sex differences in the drug's effectiveness and skepticism about its clinical benefit; Examining challenges in the nursing workforce, including burnout and understaffing; Connecting nurse burnout to blood supply shortages; Exploring the scientific process of making universal donor blood in the lab and the challenges ahead.

JAMA Editor in Chief and Harvard's dean for medical education discuss AI's impact on medical education, including interactive learning, AI tools like ChachiPT for clinical decision-making, and challenges in training faculty.

Dr. Andrew Bindman, CMO of Kaiser Permanente, discusses the impact of AI in healthcare, addressing equity, patient privacy, and social risk factors. The conversation explores the use of AI technologies in improving patient care, managing biases, and maximizing health outcomes by addressing social determinants. The discussion also emphasizes striking a balance between the promises and risks of AI in healthcare innovation, focusing on patient-centric practices and enhancing healthcare experiences.

Dr. Kedar S. Mate discusses AI's role in healthcare quality and equity. Topics include challenges in implementing evidence-based care, the evolution of the Institute for Healthcare Improvement, integrating equity and AI in healthcare systems, biases and risks of digital algorithms, and addressing bias in AI training data for equitable healthcare outcomes.

JAMA Editor in Chief and a professor of pediatrics discuss how AI can reduce clinician burden and streamline health systems. Topics include AI in the back office of healthcare, types of studies needed in AI and clinical practice, equitable considerations in applying new technologies, and transforming electronic health records with AI.

Discussion on a new blood test for Alzheimer's disease risk and the impact of wildfires on air quality and health. Opinions of experts on the test and effects of wildfires on air quality. Disproportionate impact of wildfire smoke and air pollution on vulnerable communities.

JAMA Editor in Chief Kirsten Bibbins-Domingo and UCSF's Chief Research Informatics Officer Ida Sim discuss the transformative potential of AI in medicine, exploring generative AI and large language models. They reflect on AI augmentation in medicine and the importance of AI in medical practice. The potential role of AI in clinical practice is also explored, emphasizing the need for collaboration between computer science and medical professionals in AI innovation.

Dr. Michael Howell, pulmonologist and chief clinical officer at Google, discusses AI gaslighting and hallucinations in healthcare, the collaboration between healthcare professionals and AI innovators, advancements in people intelligence and chatbot capabilities, ethics of automation bias, and safeguarding patient privacy and data in healthcare technology.